A methodological protocol for selecting and quantifying low-value prescribing practices in routinely collected data: An Australian case study

Implementation Science

Volumn 12, Issue 1, 2017, Pages

  Brett, Jonathan ^a   Elshaug, Adam G ^b   Bhatia, R Sacha ^c,d   Chalmers, Kelsey ^b   Badgery Parker, Tim ^b   Pearson, Sallie Anne ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF TORONTO   (Canada)

^d WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

Low value care; Medicines; Prescribing; Protocol; Routinely collected data

Indexed keywords

AUSTRALIA; HEALTH CARE POLICY; HUMAN; MEDICAL RESEARCH; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PREVALENCE; PUBLIC HEALTH; QUANTITATIVE STUDY; RESEARCH ETHICS; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE QUALITY; INFORMATION PROCESSING; PROCEDURES; STATISTICS AND NUMERICAL DATA;

AUSTRALIA; COST-BENEFIT ANALYSIS; DATA COLLECTION; DRUG PRESCRIPTIONS; HUMANS; PRACTICE PATTERNS, PHYSICIANS'; QUALITY INDICATORS, HEALTH CARE;

EID: 85018757878     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/s13012-017-0585-9     Document Type: Article

References (69)

1. Glasziou P, Moynihan R, Richards T, Godlee F. Too much medicine; too little care. Br Med J. 2013;347.
2. Fisher ES, Bynum JP, Skinner JS. Slowing the growth of health care costs-lessons from regional variation. N Engl J Med. 2009;360(9):849-52.
3. Elshaug AG, McWilliams JM, Landon BE. The value of low-value lists. JAMA. 2013;309(8):775-6.
4. Malhotra A, Maughan D, Ansell J, Lehman R, Henderson A, Gray M, et al. Choosing Wisely in the UK: the Academy of Medical Royal Colleges' initiative to reduce the harms of too much medicine. Br Med J. 2015;350:h2308.
5. Bhatia RS, Levinson W, Shortt S, Pendrith C, Fric-Shamji E, Kallewaard M, et al. Measuring the effect of Choosing Wisely: an integrated framework to assess campaign impact on low-value care. British Med J Qual Saf. 2015;24(8):523-31.
6. Garner S, Littlejohns P. Disinvestment from low value clinical interventions: NICEly done? Br Med J. 2011;343:d4519.
7. Brody H. Medicine's ethical responsibility for health care reform-the top five list. N Engl J Med. 2010;362(4):283-5.
8. Morden NE, Colla CH, Sequist TD, Rosenthal MB. Choosing wisely-the politics and economics of labeling low-value services. N Engl J Med. 2014;370(7):589-92.
9. Campanelli CM. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults: the American Geriatrics Society 2012 Beers Criteria Update Expert Panel. J Am Geriatr Soc. 2012;60(4):616.
10. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72-83.
11. Levinson W, Kallewaard M, Bhatia RS, Wolfson D, Shortt S, Kerr EA, et al. 'Choosing Wisely': a growing international campaign. BMJ Quality & Safety. 2014:bmjqs-2014-003821.
12. Gliwa C, Pearson SD. Evidentiary rationales for the Choosing Wisely top 5 lists. JAMA. 2014;311(14):1443-4.
13. Soon J, Buchbinder R, Close J, Hill C, Allan S, Turnour C. Identifying low-value care: the Royal Australasian College of Physicians' EVOLVE initiative. Med J Aust. 2016;204(5):180.
14. JAMA Internal Medicine. Less Is More Collection. Available from: http://jamanetwork.com/collections/6017/less-is-more. Accessed Jan 2017.
15. Journal BM. Too Much Medicine. Available from: http://www.bmj.com/too-much-medicine. Accessed Jan 2017.
16. Kelman CW, Pearson S, Day RO, Holman CDJ, Kliewer EV, Henry DA. Evaluating medicines: let's use all the evidence. Med J Aust. 2007;186(5):249.
17. Collins B. Big Data and health economics: strengths, weaknesses, opportunities and threats. PharmacoEconomics. 2015:1-6
18. Schwartz AL, Landon BE, Elshaug AG, Chernew ME, McWilliams JM. Measuring low-value care in Medicare. JAMA Intern Med. 2014;174(7):1067-76.
19. Chan KS, Chang E, Nassery N, Chang H-Y, Segal JB. The state of overuse measurement: a critical review. Med Care Res Rev. 2013;70(5):473-96.
20. Pearson SA, Pesa N, Langton JM, Drew A, Faedo M, Robertson J. Studies using Australia's Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: a systematic review of the published literature (1987-2013). Pharmacoepidemiol Drug Saf. 2015;24(5):447-55.
21. Wettermark B, Zoega H, Furu K, Korhonen M, Hallas J, Nørgaard M, et al. The Nordic prescription databases as a resource for pharmacoepidemiological research-a literature review. Pharmacoepidemiol Drug Saf. 2013;22(7):691-9.
22. Roughead E, Anderson B, Gilbert AL. Potentially inappropriate prescribing among Australian veterans and war widows/widowers. Intern Med J. 2007;37(6):402-5.
23. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol. 2010;69(5):543-52.
24. Essock SM, Covell NH, Leckman-Westin E, Lieberman JA, Sederer LI, Kealey E, et al. Identifying clinically questionable psychotropic prescribing practices for Medicaid recipients in New York state. Psychiatr Serv. 2009;60(12):1595-602.
25. de Vries EF, Struijs JN, Heijink R, Hendrikx RJ, Baan CA. Are low-value care measures up to the task? A systematic review of the literature. BMC Health Serv Res. 2016;16(1):1.
26. Rosenberg A, Agiro A, Gottlieb M, Barron J, Brady P, Liu Y, et al. Early trends among seven recommendations from the Choosing Wisely campaign. JAMA Intern Med. 2015;175(12):1913-20.
27. Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA. 2016;315(17):1864-73.
28. Schwartz AL, Zaslavsky AM, Landon BE, Chernew ME, McWilliams JM. Low value service use in provider organizations. Health Serv Res. 2016.
29. Strom BL. Pharmacoepidemiology: John Wiley & Sons; 2006
30. Reeve J, Sweidan M. Setting a standard for electronic prescribing systems. Aust Prescr. 2011;34(1):2.
31. Australian Government Department of Health and Aging. The eHealth readiness of Australia's medical specialists. 2011.
32. National Prescribing Service. What is Medicine Insight? 2015. Available from: http://www.nps.org.au/health-professionals/medicineinsight. Accessed Jan 2017.
33. DeVoe JE, Gold R, McIntire P, Puro J, Chauvie S, Gallia CA. Electronic health records vs Medicaid claims: completeness of diabetes preventive care data in community health centers. Ann Fam Med. 2011;9(4):351-8.
34. Mellish L, Karanges EA, Litchfield MJ, Schaffer AL, Blanch B, Daniels BJ, et al. The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers. BMC Res Notes. 2015;8(1):634.
35. Leach MJ, Pratt NL, Roughead EE. Psychoactive medicine use and the risk of hip fracture in older people: a case crossover study. Pharmacoepidemiol Drug Saf. 2015.
36. Pratt NL, Ramsay EN, Ellett LMK, Nguyen TA, Barratt JD, Roughead EE. Association between use of multiple psychoactive medicines and hospitalization for falls: retrospective analysis of a large healthcare claim database. Drug Saf. 2014;37(7):529-35.
37. Leape LL, Park RE, Solomon DH, Chassin MR, Kosecoff J, Brook RH. Does inappropriate use explain small-area variations in the use of health care services? JAMA. 1990;263(5):669-72.
38. Care. ACoSaQiH. Australian Atlas of Healthcare Variation 2016. Available from: http://www.safetyandquality.gov.au/atlas/. Accessed Jan 2017.
39. Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006;60(4):290-7.
40. Lagarde M. How to do (or not to do). Assessing the impact of a policy change with routine longitudinal data. Health Policy Plan. 2012;27(1):76-83.
41. Schaffer AL, Buckley NA, Dobbins TA, Banks E, Pearson S-A. The crux of the matter: did the ABC's catalyst program change statin use in Australia? Med J Aust. 2015;202(11):591-4.
42. Pharmaceutical Benefits Advisory Committee. Streamline authority initiative review. 2008.
43. Box GE, Jenkins GM, Reinsel GC, Ljung GM. Time series analysis: forecasting and control: John Wiley & Sons; 2015
44. Wahab IA, Pratt NL, Wiese MD, Kalisch LM, Roughead EE. The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection. Pharmacoepidemiol Drug Saf. 2013;22(5):496-502.
45. Vitry A, Wong SA, Roughead EE, Ramsay E, Barratt J. Validity of medication-based co-morbidity indices in the Australian elderly population. Aust N Z J Public Health. 2009;33(2):126-30.
46. Sloan KL, Sales AE, Liu C-F, Fishman P, Nichol P, Suzuki NT, et al. Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care. 2003;41(6):761-74.
47. Gallego JA, Nielsen J, De Hert M, Kane JM, Correll CU. Safety and tolerability of antipsychotic polypharmacy. Expert Opin Drug Saf. 2012;11(4):527-42.
48. Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf. 2009;18(6):483-91.
49. Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772-9.
50. Ramsay EN, Pratt NL, Ryan P, Roughead EE. Proton pump inhibitors and the risk of pneumonia: a comparison of cohort and self-controlled case series designs. BMC Med Res Methodol. 2013;13(1):82.
51. Douglas IJ, Smeeth L. Exposure to antipsychotics and risk of stroke: self controlled case series study. Br Med J. 2008;337:a1227.
52. Pratt NL, Roughead EE, Ramsay E, Salter A, Ryan P. Risk of hospitalization for stroke associated with antipsychotic use in the elderly. Drugs Aging. 2010;27(11):885-93.
53. Jackson T. Cost estimates for hospital inpatient care in Australia: evaluation of alternative sources. Aust N Z J Public Health. 2000;24(3):234-41.
54. Levinson W. Searching for effective innovations I: reducing low-value care. Webinar. Washington: Academy of Health; 2015. Available from: http://www.academyhealth.org/Events/events.cfm?ItemNumber=16876. Accessed Jan 2017.
55. MacKenzie A. Balancing the benefits and risks of empirical antibiotics for sinusitis: a teachable moment. JAMA Intern Med. 2014;174(8):1221-2.
56. Lader M. Benzodiazepines revisited-will we ever learn? Addiction. 2011;106(12):2086-109.
57. Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med. 2010;170(9):784-90.
58. Abraham NS. Proton pump inhibitors: potential adverse effects. Curr Opin Gastroenterol. 2012;28(6):615-20.
59. McKean A, Monasterio E. Off-label use of atypical antipsychotics. CNS Drugs. 2012;26(5):383-90.
60. Dull RB, Friedman SK, Risoldi ZM, Rice EC, Starlin RC, Destache CJ. Antimicrobial treatment of asymptomatic bacteriuria in noncatheterized adults: a systematic review. Pharmacotherapy. 2014;34(9):941-60.
61. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J. 2004;329(7456):15-9.
62. Rahman S, Malcoun A. Nonsteroidal antiinflammatory drugs, cyclooxygenase-2, and the kidneys. Prim Care. 2014;41(4):803-21.
63. Fernandez-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, et al. Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metabol. 2010;95(6):2560-75.
64. Choosing Wisely USA. Available from: http://www.choosingwisely.org/. Accessed Jan 2017.
65. Choosing Wisely Canada. Available from: http://www.choosingwiselycanada.org/. Accessed Jan 2017.
66. Slow Medicine. Choosing Wisely the Italian Project. Available from: http://www.choosingwiselyitaly.org/index.php/it/. Accessed Apr 2017.
67. Choosing Wisely Australia. Available from: http://www.choosingwisely.org.au/home. Accessed Jan 2017.
68. Choosing Wisely Netherlands Campaign. Available from: http://www.demedischspecialist.nl/file/314/download?token=dewWtajm. Accessed Jan 2017.
69. Smarter Medicine Switzerland. Available from: http://www.smartermedicine.ch/de. Accessed Jan 2017.